Association of quality of life with anticoagulant control in patients with heart failure: The Warfarin and Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) trial

Jonathan A Shaffer; John L.P Thompson; Bin Cheng; Siqin Ye; Gregory Y.H Lip; Douglas L Mann; Ralph L Sacco; Patrick M Pullicino; Ronald S Freudenberger; Susan Graham; J.P Mohr; Arthur J Labovitz; Conrado J Estol; Dirk J Lok; Piotr Ponikowski; Stefan D Anker; Marco R Di Tullio; Shunichi Homma

doi:10.1016/j.ijcard.2014.10.012

Back

Association of quality of life with anticoagulant control in patients with heart failure: The Warfarin and Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) trial

Journal article

Open access

Peer reviewed

Association of quality of life with anticoagulant control in patients with heart failure: The Warfarin and Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) trial

Jonathan A Shaffer, John L.P Thompson, Bin Cheng, Siqin Ye, Gregory Y.H Lip, Douglas L Mann, Ralph L Sacco, Patrick M Pullicino, Ronald S Freudenberger, Susan Graham, …

International journal of cardiology, Vol.177(2), pp.715-717

2014-12-15

DOI: https://doi.org/10.1016/j.ijcard.2014.10.012

PMCID: PMC4303491

PMID: 25456692

Abstract

Heart failure

Anticoagulant

Quality of life

Files and links (1)

url

https://doi.org/10.1016/j.ijcard.2014.10.012View

Published (Version of record) Open

Metrics

7 Record Views

2 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration; International collaboration
Citation topics: 1 Clinical & Life Sciences; 1.94 Cardiac Arrhythmia; 1.94.95 Atrial Fibrillation
Web Of Science research areas: Cardiac & Cardiovascular Systems
ESI research areas: Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: Association of quality of life with anticoagulant control in patients with heart failure: The Warfarin and Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) trial
Creators: Jonathan A Shaffer - Columbia University Medical Center, New York, United States
John L.P Thompson - Columbia University Medical Center, New York, United States
Bin Cheng - Columbia University Medical Center, New York, United States
Siqin Ye - Columbia University Medical Center, New York, United States
Gregory Y.H Lip - University of Birmingham Centre for Cardiovascular Sciences, Birmingham, United Kingdom
Douglas L Mann - Washington University, St. Louis, United States
Ralph L Sacco - University of Miami, Miami, United States
Patrick M Pullicino - University of Kent, Canterbury, United Kingdom
Ronald S Freudenberger - Lehigh Valley Hospital, Allentown, PA, United States
Susan Graham - State University of New York at Buffalo, Buffalo, United States
J.P Mohr - Columbia University Medical Center, New York, United States
Arthur J Labovitz - University of South Florida, Tampa, United States
Conrado J Estol - Centro Neurológico de Tratamiento y Rehabilitación, Buenos Aires, Argentina
Dirk J Lok - Hospital Deventer, Deventer, Netherlands
Piotr Ponikowski - Military Hospital, Wroclaw, Poland
Stefan D Anker - Department of Innovative Clinical Trials, University Medical Centre Göttingen, Göttingen, Germany
Marco R Di Tullio - Columbia University Medical Center, New York, United States
Shunichi Homma - Columbia University Medical Center, New York, United States
Publication Details: International journal of cardiology, Vol.177(2), pp.715-717
Publisher: Elsevier Ireland Ltd
Academic Unit: Leadership Department; Miller School of Medicine; UMMG Department of Neurology
Language: English
Resource Type: Journal article
PMID: 25456692
PMCID: PMC4303491
Record Identifier: 991031560832502976